WC
CELG

Wexford Capital’s Celgene Corp CELG Stock Holding History

Wexford Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,700
Closed -$351K – 214
2017
Q2 		$351K Buy
+2,700
New +$331K 0.03% 137
2016
Q2 		– Sell
-20,413
Closed -$2.04M – 145
2016
Q1 		$2.04M Sell
20,413
-1,911
-9% -$197K 0.4% 65
2015
Q4 		$2.67M Sell
22,324
-7,897
-26% -$914K 0.63% 40
2015
Q3 		$3.27M Buy
+30,221
New +$3.75M 0.63% 49
2014
Q4 		– Sell
-118,080
Closed -$11.2M – 118
2014
Q3 		$11.2M Buy
+118,080
New +$10.7M 1.03% 13
2014
Q1 		– Sell
-4,000
Closed -$338K – 305
2013
Q4 		$338K Sell
4,000
-18,200
-82% -$1.44M 0.03% 184
2013
Q3 		$1.71M Buy
+22,200
New +$1.56M 0.14% 84

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wexford Capital's CELG Position: Q3 2017 in Review

Wexford Capital sold out of Celgene Corp (CELG) in Q3 2017, closing a stake of 2,700 shares — an estimated $351K sold.

Wexford Capital first reported a position in CELG in Q3 2013 and held it in 7 quarters. The position peaked at $11.2M in Q3 2014. 1,484 funds tracked by Wall St. Rank hold CELG as of Q3 2017.

  • Wexford Capital reported no remaining Celgene Corp position as of Q3 2017 after selling out during the quarter.
  • Wexford Capital sold 2,700 Celgene Corp shares in Q3 2017, an estimated $351K.
  • Wexford Capital first reported a position in Celgene Corp in Q3 2013 and held it in 7 quarters.
  • Wexford Capital's Celgene Corp position peaked at $11.2M in Q3 2014.
  • 1,484 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2017.

Based on Wexford Capital's 13F filing for Q3 2017, filed 13 Nov 2017.